on Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals.
As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights informs, educates and connects professionals around the globe with the aim to curb Antimicrobial resistance.
AMR Insights is committed to eliminating antimicrobial resistance because it does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms.
Achieving Universal Health Coverage while addressing Antimicrobial Resistance
This year’s conference will focus on the connection between achieving universal health coverage (UHC) and antimicrobial resistance (AMR). Specifically, the conference will focus on how addressing AMR is a path to attaining UHC and what country programs can be leveraged on.
23/07/2019 - 25/07/2019 | Nairobi (Kenia)
ASM/ESCMID Conference on Drug Development
Meet the challenge of Antimicrobial Research
03/09/2019 - 06/09/2019 | Boston (MA) USA
Latest news on AMR
Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan
Clinical Enterobacteriacae isolates with a colistin minimum inhibitory concentration (MIC) ≥4 mg/L from a United States hospital were screened for the mcr-1 gene using real-time polymerase chain reaction (RT-PCR) and confirmed by whole-genome sequencing.
Stay tuned with remarkable global AMR news and developments!